Compston, J. E., McClung, M. R. & Leslie, W. D. Osteoporosis. Lancet 393, 364–376 (2019).

Article  CAS  PubMed  Google Scholar 

Shuhart, C. et al. Executive summary of the 2023 Adult Position Development Conference of the International Society for Clinical Densitometry: DXA reporting, follow-up BMD testing and trabecular bone score application and reporting. J. Clin. Densitom. 27, 101435 (2024).

Article  PubMed  Google Scholar 

Frax calculation tool. Osteoporosis Research https://www.fraxplus.org/calculation-tool (2026).

Camacho, P. M. et al. American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis — 2020 update. Endocr. Pract. 26 (suppl. 1), 1–46 (2020).

Article  PubMed  Google Scholar 

Ebeling, P. R. et al. Secondary osteoporosis. Endocr. Rev. 43, 240–313 (2022).

Article  PubMed  Google Scholar 

Lewiecki, E. M. Evaluating patients for secondary causes of osteoporosis. Curr. Osteoporos. Rep. 20, 1–12 (2022).

Article  PubMed  Google Scholar 

Hofbauer, L. C., Hamann, C. & Ebeling, P. R. Approach to the patient with secondary osteoporosis. Eur. J. Endocrinol. 162, 1009–1020 (2010).

Article  CAS  PubMed  Google Scholar 

Painter, S. E., Kleerekoper, M. & Camacho, P. M. Secondary osteoporosis: a review of the recent evidence. Endocr. Pract. 12, 436–445 (2006).

Article  PubMed  Google Scholar 

Anastasilaki, E., Paccou, J., Gkastaris, K. & Anastasilakis, A. D. Glucocorticoid-induced osteoporosis: an overview with focus on its prevention and management. Hormones 22, 611–622 (2023).

Article  PubMed  Google Scholar 

Wallace, B. I. et al. Prevalence and prescribing patterns of oral corticosteroids in the United States, Taiwan, and Denmark, 2009–2018. Clin. Transl. Sci. 16, 2565–2576 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Vries, F. et al. Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum. 56, 208–214 (2007).

Article  PubMed  Google Scholar 

van Staa, T. P., Leufkens, H. G. & Cooper, C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos. Int. 13, 777–787 (2002).

Article  PubMed  Google Scholar 

Van Staa, T. P., Leufkens, H. G., Abenhaim, L., Zhang, B. & Cooper, C. Use of oral corticosteroids and risk of fractures. J. Bone Min. Res. 15, 993–1000 (2000).

Article  Google Scholar 

Saeedi, P. et al. IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract. 157, 107843 (2019).

Article  PubMed  Google Scholar 

Kvist, A. V., Nasser, M. I., Vestergaard, P., Frost, M. & Burden, A. M. Site-specific fracture incidence rates among patients with type 1 diabetes, type 2 diabetes, or without diabetes in Denmark (1997–2017). Diabetes Care 46, 633–642 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Wang, B. et al. Unmasking fracture risk in type 2 diabetes: the association of longitudinal glycemic hemoglobin level and medications. J. Clin. Endocrinol. Metab. 107, e1390–e1401 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Liu, X., Chen, F., Liu, L. & Zhang, Q. Prevalence of osteoporosis in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies. BMC Endocr. Disord. 23, 1 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Vilaca, T. et al. The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: a systematic review and meta-analysis update. Bone 137, 115457 (2020).

Article  PubMed  Google Scholar 

Koromani, F. et al. Vertebral fractures in individuals with type 2 diabetes: more than skeletal complications alone. Diabetes Care 43, 137–144 (2020).

Article  PubMed  Google Scholar 

Hofbauer, L. C. et al. Bone fragility in diabetes: novel concepts and clinical implications. Lancet Diabetes Endocrinol. 10, 207–220 (2022).

Article  PubMed  Google Scholar 

Silén, Y. & Keski-Rahkonen, A. Worldwide prevalence of DSM-5 eating disorders among young people. Curr. Opin. Psychiatry 35, 362–371 (2022).

Article  PubMed  Google Scholar 

Søeby, M., Gribsholt, S. B., Clausen, L. & Richelsen, B. Fracture risk in patients with anorexia nervosa over a 40-year period. J. Bone Min. Res. 38, 1586–1593 (2023).

Article  Google Scholar 

Hung, C., Muñoz, M. & Shibli-Rahhal, A. Anorexia nervosa and osteoporosis. Calcif. Tissue Int. 110, 562–575 (2022).

Article  CAS  PubMed  Google Scholar 

Guañabens, N. & Parés, A. Osteoporosis in chronic liver disease. Liver Int. 38, 776–785 (2018).

Article  PubMed  Google Scholar 

Chen, Y. W., Ramsook, A. H., Coxson, H. O., Bon, J. & Reid, W. D. Prevalence and risk factors for osteoporosis in individuals with COPD: a systematic review and meta-analysis. Chest 156, 1092–1110 (2019).

Article  PubMed  Google Scholar 

Briot, K., Geusens, P., Em Bultink, I., Lems, W. F. & Roux, C. Inflammatory diseases and bone fragility. Osteoporos. Int. 28, 3301–3314 (2017).

Article  CAS  PubMed  Google Scholar 

Szafors, P. et al. Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis. Osteoporos. Int. 29, 2389–2397 (2018).

Article  CAS  PubMed  Google Scholar 

Schett, G. Effects of inflammatory and anti-inflammatory cytokines on the bone. Eur. J. Clin. Invest. 41, 1361–1366 (2011).

Article  CAS  PubMed  Google Scholar 

Tanaka, Y. & Ohira, T. Mechanisms and therapeutic targets for bone damage in rheumatoid arthritis, in particular the RANK-RANKL system. Curr. Opin. Pharmacol. 40, 110–119 (2018).

Article  CAS  PubMed  Google Scholar 

Garnero, P., Tabassi, N. C.-B. & Voorzanger-Rousselot, N. Circulating dickkopf-1 and radiological progression in patients with early rheumatoid arthritis treated with etanercept. J. Rheumatol. 35, 2313–2315 (2008).

Article  CAS  PubMed  Google Scholar 

Bassett, J. H. & Williams, G. R. Role of thyroid hormones in skeletal development and bone maintenance. Endocr. Rev. 37, 135–187 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pepe, J. et al. Osteoporosis in premenopausal women: a clinical narrative review by the ECTS and the IOF. J. Clin. Endocrinol. Metab. 105, dgaa306 (2020).

Article  PubMed  Google Scholar 

Bandeira, L., Silva, B. C. & Bilezikian, J. P. Male osteoporosis. Arch. Endocrinol. Metab. 66, 739–747 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Silva, B. C., Cusano, N. E. & Bilezikian, J. P. Primary hyperparathyroidism. Best Pract. Res. Clin. Endocrinol. Metab. 38, 101247 (2024).

Article  CAS  PubMed  Google Scholar 

Caffarelli, C. et al. Bone fragility and sarcoidosis: an underestimated relationship. Front. Med. 9, 1026028 (2022).

Article  Google Scholar 

Pazianas, M. & Miller, P. D. Osteoporosis and chronic kidney disease-mineral and bone disorder (CKD-MBD): back to basics. Am. J. Kidney Dis. 78, 582–589 (2021).